▶ 調査レポート

心臓マーカーポイントオブケア検出装置の世界市場見通し2023年-2029年

• 英文タイトル:Cardiac Markers Point-of-care Detection Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが調査・発行した産業分析レポートです。心臓マーカーポイントオブケア検出装置の世界市場見通し2023年-2029年 / Cardiac Markers Point-of-care Detection Market, Global Outlook and Forecast 2023-2029 / MRC2312MG11844資料のイメージです。• レポートコード:MRC2312MG11844
• 出版社/出版日:Market Monitor Global / 2023年12月
• レポート形態:英文、PDF、103ページ
• 納品方法:Eメール(納期:3営業日)
• 産業分類:医療機器&消耗品
• 販売価格(消費税別)
  Single User¥481,000 (USD3,250)▷ お問い合わせ
  Enterprise User¥721,500 (USD4,875)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査レポートは次の情報を含め、世界の心臓マーカーポイントオブケア検出装置市場規模と予測を収録しています。・世界の心臓マーカーポイントオブケア検出装置市場:売上、2018年-2023年、2024年-2029年
・世界の心臓マーカーポイントオブケア検出装置市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の心臓マーカーポイントオブケア検出装置市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「医療機器」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

心臓マーカーポイントオブケア検出装置のグローバル主要企業は、Alere、 Roche、 Abbott、 BioMérieux、 LSI Medience Corporation、 Randox laboratories Ltd、 Guangzhou Wondfo Biotechnology Co., Ltd.、 Getein Biotech、 ReLIA、 Lepu Medical、 Goldsite、 Lifotronic、 Hotgen、 Ediagnosis、 POCTなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、心臓マーカーポイントオブケア検出装置のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の心臓マーカーポイントオブケア検出装置市場:タイプ別、2018年-2023年、2024年-2029年
世界の心臓マーカーポイントオブケア検出装置市場:タイプ別市場シェア、2022年
・医療機器、消耗品

世界の心臓マーカーポイントオブケア検出装置市場:用途別、2018年-2023年、2024年-2029年
世界の心臓マーカーポイントオブケア検出装置市場:用途別市場シェア、2022年
・病院、診療所、その他

世界の心臓マーカーポイントオブケア検出装置市場:地域・国別、2018年-2023年、2024年-2029年
世界の心臓マーカーポイントオブケア検出装置市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における心臓マーカーポイントオブケア検出装置のグローバル売上、2018年-2023年
・主要企業における心臓マーカーポイントオブケア検出装置のグローバル売上シェア、2022年
・主要企業における心臓マーカーポイントオブケア検出装置のグローバル販売量、2018年-2023年
・主要企業における心臓マーカーポイントオブケア検出装置のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Alere、 Roche、 Abbott、 BioMérieux、 LSI Medience Corporation、 Randox laboratories Ltd、 Guangzhou Wondfo Biotechnology Co., Ltd.、 Getein Biotech、 ReLIA、 Lepu Medical、 Goldsite、 Lifotronic、 Hotgen、 Ediagnosis、 POCT

*************************************************************

・調査・分析レポートの概要
心臓マーカーポイントオブケア検出装置市場の定義
市場セグメント
世界の心臓マーカーポイントオブケア検出装置市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の心臓マーカーポイントオブケア検出装置市場規模
世界の心臓マーカーポイントオブケア検出装置市場規模:2022年 VS 2029年
世界の心臓マーカーポイントオブケア検出装置市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの心臓マーカーポイントオブケア検出装置の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の心臓マーカーポイントオブケア検出装置製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:医療機器、消耗品
心臓マーカーポイントオブケア検出装置のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院、診療所、その他
心臓マーカーポイントオブケア検出装置の用途別グローバル売上・予測

・地域別市場分析
地域別心臓マーカーポイントオブケア検出装置市場規模 2022年と2029年
地域別心臓マーカーポイントオブケア検出装置売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Alere、 Roche、 Abbott、 BioMérieux、 LSI Medience Corporation、 Randox laboratories Ltd、 Guangzhou Wondfo Biotechnology Co., Ltd.、 Getein Biotech、 ReLIA、 Lepu Medical、 Goldsite、 Lifotronic、 Hotgen、 Ediagnosis、 POCT
...

This research report provides a comprehensive analysis of the Cardiac Markers Point-of-care Detection market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Cardiac Markers Point-of-care Detection market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Cardiac Markers Point-of-care Detection, challenges faced by the industry, and potential opportunities for market players.
The global Cardiac Markers Point-of-care Detection market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Cardiac Markers Point-of-care Detection market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Cardiac Markers Point-of-care Detection market. Additionally, the growing consumer demand present avenues for market expansion.
The global Cardiac Markers Point-of-care Detection market was valued at US$ 3301.1 million in 2022 and is projected to reach US$ 6111.9 million by 2029, at a CAGR of 9.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The cardiac marker point-of-care testing market has witnessed significant growth in recent years, driven by rising prevalence of cardiovascular diseases, advancements in POC technology, and emphasis on personalized medicine.
Key Features:
The research report on the Cardiac Markers Point-of-care Detection market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Cardiac Markers Point-of-care Detection market.
Market Overview: The report provides a comprehensive overview of the Cardiac Markers Point-of-care Detection market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Medical Equipment, Consumables), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Cardiac Markers Point-of-care Detection market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Cardiac Markers Point-of-care Detection market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Cardiac Markers Point-of-care Detection market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Cardiac Markers Point-of-care Detection market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Cardiac Markers Point-of-care Detection market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Cardiac Markers Point-of-care Detection market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Cardiac Markers Point-of-care Detection, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Cardiac Markers Point-of-care Detection market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Cardiac Markers Point-of-care Detection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Medical Equipment
Consumables
Market segment by Application
Hospital
Clinic
Other
Global Cardiac Markers Point-of-care Detection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Alere
Roche
Abbott
BioMérieux
LSI Medience Corporation
Randox laboratories Ltd
Guangzhou Wondfo Biotechnology Co., Ltd.
Getein Biotech
ReLIA
Lepu Medical
Goldsite
Lifotronic
Hotgen
Ediagnosis
POCT
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cardiac Markers Point-of-care Detection, market overview.
Chapter 2: Global Cardiac Markers Point-of-care Detection market size in revenue.
Chapter 3: Detailed analysis of Cardiac Markers Point-of-care Detection company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cardiac Markers Point-of-care Detection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

レポート目次

1 Introduction to Research & Analysis Reports
1.1 Cardiac Markers Point-of-care Detection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cardiac Markers Point-of-care Detection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cardiac Markers Point-of-care Detection Overall Market Size
2.1 Global Cardiac Markers Point-of-care Detection Market Size: 2022 VS 2029
2.2 Global Cardiac Markers Point-of-care Detection Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cardiac Markers Point-of-care Detection Players in Global Market
3.2 Top Global Cardiac Markers Point-of-care Detection Companies Ranked by Revenue
3.3 Global Cardiac Markers Point-of-care Detection Revenue by Companies
3.4 Top 3 and Top 5 Cardiac Markers Point-of-care Detection Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cardiac Markers Point-of-care Detection Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cardiac Markers Point-of-care Detection Players in Global Market
3.6.1 List of Global Tier 1 Cardiac Markers Point-of-care Detection Companies
3.6.2 List of Global Tier 2 and Tier 3 Cardiac Markers Point-of-care Detection Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Cardiac Markers Point-of-care Detection Market Size Markets, 2022 & 2029
4.1.2 Medical Equipment
4.1.3 Consumables
4.2 By Type – Global Cardiac Markers Point-of-care Detection Revenue & Forecasts
4.2.1 By Type – Global Cardiac Markers Point-of-care Detection Revenue, 2018-2023
4.2.2 By Type – Global Cardiac Markers Point-of-care Detection Revenue, 2024-2029
4.2.3 By Type – Global Cardiac Markers Point-of-care Detection Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Cardiac Markers Point-of-care Detection Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Cardiac Markers Point-of-care Detection Revenue & Forecasts
5.2.1 By Application – Global Cardiac Markers Point-of-care Detection Revenue, 2018-2023
5.2.2 By Application – Global Cardiac Markers Point-of-care Detection Revenue, 2024-2029
5.2.3 By Application – Global Cardiac Markers Point-of-care Detection Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Cardiac Markers Point-of-care Detection Market Size, 2022 & 2029
6.2 By Region – Global Cardiac Markers Point-of-care Detection Revenue & Forecasts
6.2.1 By Region – Global Cardiac Markers Point-of-care Detection Revenue, 2018-2023
6.2.2 By Region – Global Cardiac Markers Point-of-care Detection Revenue, 2024-2029
6.2.3 By Region – Global Cardiac Markers Point-of-care Detection Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Cardiac Markers Point-of-care Detection Revenue, 2018-2029
6.3.2 US Cardiac Markers Point-of-care Detection Market Size, 2018-2029
6.3.3 Canada Cardiac Markers Point-of-care Detection Market Size, 2018-2029
6.3.4 Mexico Cardiac Markers Point-of-care Detection Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Cardiac Markers Point-of-care Detection Revenue, 2018-2029
6.4.2 Germany Cardiac Markers Point-of-care Detection Market Size, 2018-2029
6.4.3 France Cardiac Markers Point-of-care Detection Market Size, 2018-2029
6.4.4 U.K. Cardiac Markers Point-of-care Detection Market Size, 2018-2029
6.4.5 Italy Cardiac Markers Point-of-care Detection Market Size, 2018-2029
6.4.6 Russia Cardiac Markers Point-of-care Detection Market Size, 2018-2029
6.4.7 Nordic Countries Cardiac Markers Point-of-care Detection Market Size, 2018-2029
6.4.8 Benelux Cardiac Markers Point-of-care Detection Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Cardiac Markers Point-of-care Detection Revenue, 2018-2029
6.5.2 China Cardiac Markers Point-of-care Detection Market Size, 2018-2029
6.5.3 Japan Cardiac Markers Point-of-care Detection Market Size, 2018-2029
6.5.4 South Korea Cardiac Markers Point-of-care Detection Market Size, 2018-2029
6.5.5 Southeast Asia Cardiac Markers Point-of-care Detection Market Size, 2018-2029
6.5.6 India Cardiac Markers Point-of-care Detection Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Cardiac Markers Point-of-care Detection Revenue, 2018-2029
6.6.2 Brazil Cardiac Markers Point-of-care Detection Market Size, 2018-2029
6.6.3 Argentina Cardiac Markers Point-of-care Detection Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Cardiac Markers Point-of-care Detection Revenue, 2018-2029
6.7.2 Turkey Cardiac Markers Point-of-care Detection Market Size, 2018-2029
6.7.3 Israel Cardiac Markers Point-of-care Detection Market Size, 2018-2029
6.7.4 Saudi Arabia Cardiac Markers Point-of-care Detection Market Size, 2018-2029
6.7.5 UAE Cardiac Markers Point-of-care Detection Market Size, 2018-2029
7 Cardiac Markers Point-of-care Detection Companies Profiles
7.1 Alere
7.1.1 Alere Company Summary
7.1.2 Alere Business Overview
7.1.3 Alere Cardiac Markers Point-of-care Detection Major Product Offerings
7.1.4 Alere Cardiac Markers Point-of-care Detection Revenue in Global Market (2018-2023)
7.1.5 Alere Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Cardiac Markers Point-of-care Detection Major Product Offerings
7.2.4 Roche Cardiac Markers Point-of-care Detection Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Abbott
7.3.1 Abbott Company Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott Cardiac Markers Point-of-care Detection Major Product Offerings
7.3.4 Abbott Cardiac Markers Point-of-care Detection Revenue in Global Market (2018-2023)
7.3.5 Abbott Key News & Latest Developments
7.4 BioMérieux
7.4.1 BioMérieux Company Summary
7.4.2 BioMérieux Business Overview
7.4.3 BioMérieux Cardiac Markers Point-of-care Detection Major Product Offerings
7.4.4 BioMérieux Cardiac Markers Point-of-care Detection Revenue in Global Market (2018-2023)
7.4.5 BioMérieux Key News & Latest Developments
7.5 LSI Medience Corporation
7.5.1 LSI Medience Corporation Company Summary
7.5.2 LSI Medience Corporation Business Overview
7.5.3 LSI Medience Corporation Cardiac Markers Point-of-care Detection Major Product Offerings
7.5.4 LSI Medience Corporation Cardiac Markers Point-of-care Detection Revenue in Global Market (2018-2023)
7.5.5 LSI Medience Corporation Key News & Latest Developments
7.6 Randox laboratories Ltd
7.6.1 Randox laboratories Ltd Company Summary
7.6.2 Randox laboratories Ltd Business Overview
7.6.3 Randox laboratories Ltd Cardiac Markers Point-of-care Detection Major Product Offerings
7.6.4 Randox laboratories Ltd Cardiac Markers Point-of-care Detection Revenue in Global Market (2018-2023)
7.6.5 Randox laboratories Ltd Key News & Latest Developments
7.7 Guangzhou Wondfo Biotechnology Co., Ltd.
7.7.1 Guangzhou Wondfo Biotechnology Co., Ltd. Company Summary
7.7.2 Guangzhou Wondfo Biotechnology Co., Ltd. Business Overview
7.7.3 Guangzhou Wondfo Biotechnology Co., Ltd. Cardiac Markers Point-of-care Detection Major Product Offerings
7.7.4 Guangzhou Wondfo Biotechnology Co., Ltd. Cardiac Markers Point-of-care Detection Revenue in Global Market (2018-2023)
7.7.5 Guangzhou Wondfo Biotechnology Co., Ltd. Key News & Latest Developments
7.8 Getein Biotech
7.8.1 Getein Biotech Company Summary
7.8.2 Getein Biotech Business Overview
7.8.3 Getein Biotech Cardiac Markers Point-of-care Detection Major Product Offerings
7.8.4 Getein Biotech Cardiac Markers Point-of-care Detection Revenue in Global Market (2018-2023)
7.8.5 Getein Biotech Key News & Latest Developments
7.9 ReLIA
7.9.1 ReLIA Company Summary
7.9.2 ReLIA Business Overview
7.9.3 ReLIA Cardiac Markers Point-of-care Detection Major Product Offerings
7.9.4 ReLIA Cardiac Markers Point-of-care Detection Revenue in Global Market (2018-2023)
7.9.5 ReLIA Key News & Latest Developments
7.10 Lepu Medical
7.10.1 Lepu Medical Company Summary
7.10.2 Lepu Medical Business Overview
7.10.3 Lepu Medical Cardiac Markers Point-of-care Detection Major Product Offerings
7.10.4 Lepu Medical Cardiac Markers Point-of-care Detection Revenue in Global Market (2018-2023)
7.10.5 Lepu Medical Key News & Latest Developments
7.11 Goldsite
7.11.1 Goldsite Company Summary
7.11.2 Goldsite Business Overview
7.11.3 Goldsite Cardiac Markers Point-of-care Detection Major Product Offerings
7.11.4 Goldsite Cardiac Markers Point-of-care Detection Revenue in Global Market (2018-2023)
7.11.5 Goldsite Key News & Latest Developments
7.12 Lifotronic
7.12.1 Lifotronic Company Summary
7.12.2 Lifotronic Business Overview
7.12.3 Lifotronic Cardiac Markers Point-of-care Detection Major Product Offerings
7.12.4 Lifotronic Cardiac Markers Point-of-care Detection Revenue in Global Market (2018-2023)
7.12.5 Lifotronic Key News & Latest Developments
7.13 Hotgen
7.13.1 Hotgen Company Summary
7.13.2 Hotgen Business Overview
7.13.3 Hotgen Cardiac Markers Point-of-care Detection Major Product Offerings
7.13.4 Hotgen Cardiac Markers Point-of-care Detection Revenue in Global Market (2018-2023)
7.13.5 Hotgen Key News & Latest Developments
7.14 Ediagnosis
7.14.1 Ediagnosis Company Summary
7.14.2 Ediagnosis Business Overview
7.14.3 Ediagnosis Cardiac Markers Point-of-care Detection Major Product Offerings
7.14.4 Ediagnosis Cardiac Markers Point-of-care Detection Revenue in Global Market (2018-2023)
7.14.5 Ediagnosis Key News & Latest Developments
7.15 POCT
7.15.1 POCT Company Summary
7.15.2 POCT Business Overview
7.15.3 POCT Cardiac Markers Point-of-care Detection Major Product Offerings
7.15.4 POCT Cardiac Markers Point-of-care Detection Revenue in Global Market (2018-2023)
7.15.5 POCT Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer